- Udyam number
- UDYAM-MH-18-0146170

3S Pharmaceuticals India Private Limited
About 3S Pharmaceuticals India Private Limited
Data last updated:
3S Pharmaceuticals India Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2021PTC370327. Its GSTIN is 27AABCZ8412F1ZA (Maharashtra).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Piyansh Omprakash Mantry (Managing Director) and Omprakash Shankarlal Mantry.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A3 Bonanza Ind Estate A C Road Ashok Nagar Kandivali East, Mumbai, Maharashtra, India – 400101.
As per the financials filed for FY 2024, the company reported a revenue of ₹16.32 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹2.87 Cr (net margin 17.6%) and EBITDA of ₹3.87 Cr (EBITDA margin 23.7%).
3S Pharmaceuticals India Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-18-0146170).
Company details
Recognitions & Rankings of 3S Pharmaceuticals India
Contact details
3S Pharmaceuticals India Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressA3 Bonanza Ind Estate A C Road Ashok Nagar Kandivali East, Mumbai, Maharashtra, India – 400101
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of 3S Pharmaceuticals India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of 3S Pharmaceuticals India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of 3S Pharmaceuticals India Private Limited, buy the company report.
Financials of 3S Pharmaceuticals India Private Limited
FY 2025 filings available3S Pharmaceuticals India Private Limited reported revenue of ₹16.32 Cr (down 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 11% in the latest year. EBITDA fell 22% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹3.87 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹2.87 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 23.7% | ||
| Net Profit Margin | 17.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of 3S Pharmaceuticals India Private Limited, buy the company report.
Board of directors of 3S Pharmaceuticals India Private Limited
3S Pharmaceuticals India has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Piyansh Omprakash Mantry Also directs: Century Inks Pvt Ltd, Kalash Merchants Private Limited | Managing Director | 26 Oct 2021 | 5 Years 0 Months | Current |
| Omprakash Shankarlal Mantry Also directs: Century Inks Pvt Ltd, Spencers Commotrade Pvt. Ltd., Kalash Merchants Private Limited and 1 more | Director | 26 Oct 2021 | 5 Years 0 Months | Current |
Peer comparison
3S Pharmaceuticals India Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zanacea Biotec Private Limited | ₹16.37 Cr (FY 2025) | 4.0% | Sikar, Rajasthan, India | |||
| Vignaharta Enterprises Private Limited | ₹16.36 Cr (FY 2025) | 52.0% | Mohali, Punjab, India | |||
| Raishahib Gangaram Chowdhury & Sons Co Pvt Ltd | ₹16.35 Cr (FY 2025) | 25.0% | Assam, India | |||
| 3S Pharmaceuticals India Private Limitedthis company | ₹16.32 Cr (FY 2024) | ₹2.87 Cr | 17.6% | -11.0% | Mumbai, Maharashtra, India | |
| Osb Agencies Private Limited | ₹16.24 Cr (FY 2025) | 22.0% | Delhi, India | |||
| Gupta Medicare Pharmaceuticals Private Limited | ₹16.23 Cr (FY 2025) | 20.0% | Panchkula, Haryana, India |
To see the full peer comparison of 3S Pharmaceuticals India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving 3S Pharmaceuticals India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for 3S Pharmaceuticals India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
3S Pharmaceuticals India Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
GST
3S Pharmaceuticals India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCZ8412F1ZA | Maharashtra | Active | 17 Nov 2021 |
To see the full GST registrations and return filing status of 3S Pharmaceuticals India Private Limited, buy the company report.
Recent activity
3S Pharmaceuticals India Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Omprakash Shankarlal Mantry was appointed as Director on 26 Oct 2021.
Frequently asked questions
3S Pharmaceuticals India is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 October 2021 (5+ years old) and is registered under CIN U51909MH2021PTC370327.
3S Pharmaceuticals India has 2 current directors:
- Piyansh Omprakash Mantry - Managing Director
- Omprakash Shankarlal Mantry - Director
The latest financial statements of 3S Pharmaceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of 3S Pharmaceuticals India is 27AABCZ8412F1ZA, registered in Maharashtra.
The CIN (Corporate Identification Number) of 3S Pharmaceuticals India is U51909MH2021PTC370327. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
3S Pharmaceuticals India was incorporated on 26 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of 3S Pharmaceuticals India by revenue are Zanacea Biotec Private Limited, Vignaharta Enterprises Private Limited, Raishahib Gangaram Chowdhury & Sons Co Pvt Ltd, Osb Agencies Private Limited, Gupta Medicare Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Omprakash Shankarlal Mantry was appointed as Director on 26 Oct 2021. Piyansh Omprakash Mantry was appointed as Managing Director on 26 Oct 2021.
Yes, 3S Pharmaceuticals India is registered as an MSME under Udyam registration (number: UDYAM-MH-18-0146170).
The registered office of 3S Pharmaceuticals India is at A3 Bonanza Ind Estate A C Road Ashok Nagar Kandivali East, Mumbai, Maharashtra, India – 400101.
3S Pharmaceuticals India operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

